[CANSLIM] EPIQ and other thoughts


From: "Edward W. Gjertsen II" <ed@macktracks.com>
Subject: [CANSLIM] EPIQ and other thoughts
Date: Fri, 28 Mar 2003 13:19:51 -0600

Previous Article (by Date): Re: [CANSLIM] EPIQ and other thoughts "NANCY POLCARO"
Top of Thread: Re: [CANSLIM] EPIQ and other thoughts Ian
Articles sorted by: [Date] [Author] [Subject]


This is a multi-part message in MIME format.

- ------=_NextPart_000_00A9_01C2F52C.B7146B10
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_00AA_01C2F52C.B7146B10"


- ------=_NextPart_001_00AA_01C2F52C.B7146B10
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

Great comments Nancy - my thoughts were not necessarily directed at Tom
and definitely not a criticism of this great board.  There are members
here who put a lot of time and effort into guiding those looking to
learn.  My concern is that some here may only want to take a fish out of
the basket instead of learning to fish.  This is the most intelligent,
well versed board that I have been involved with and hope many here will
make more than just a buck.  



 

Ed Gjertsen II

 <mailto:ed@macktracks.com> ed@macktracks.com

 

 

Confidentiality Notice: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain
confidential and privileged information.  Any unauthorized review, use,
disclosure or distribution is prohibited.  If you are not the intended
recipient, please contact the sender by reply e-mail and destroy all
copies of the original message.

 

- -----Original Message-----
From: owner-canslim@lists.xmission.com
[mailto:owner-canslim@lists.xmission.com] On Behalf Of NANCY POLCARO
Sent: Monday, July 28, 2003 12:45 PM
To: canslim
Subject: Re: [CANSLIM] EPIQ and other thoughts

 

I have to say I disagree with your thoughts on Toms message aabout
EPIQ.. If he had said "what do you think about EPIQ".  Instead of "I
like EPIQ". No would have complained.  I said that very thing about
Yahoo a couple of weeks ago and no one said anything to me for letting
the cat out of the bag and drawing attention to a stock that was doing
well.  I believe another one brought up on the board was ONEV.  Again
asking for opinions.  For the people that are  less experienced and
learning in this terrible market, it may actually help them make a buck.
I think the board should set a rule for the future where everyone who
want to bring attention to a stock should say " What do you think about
this stock"  Then it will bring it to our attention, we can ask
questions, we can get answers, and no one will get upset for " letting
the cat out of the bag."nancy

 

- ----- Original Message -----

From: Ian

Sent: Monday, July 28, 2003 9:24 AM

To: canslim@lists.xmission.com

Subject: Re: [CANSLIM] EPIQ and other thoughts

 

I would reiterate Ed's assertion that generic pharma and a few other
medicaldevice makers are leading this market. A couple of days ago, when
the
market was flat, I was watching about 15 pharma/medical stocks up 4% or
more. It is the sector that I'd be most comfortable taking long
positions in
right now when the charts set up.



Ian


- ----- Original Message -----
From: Edward W. Gjertsen II <ed@macktracks.com>
To: <canslim@lists.xmission.com>
Sent: Thursday, March 27, 2003 4:40 PM
Subject: [CANSLIM] EPIQ and other thoughts


> Tom, Tom, Tom --- This is one we are watching as well - my own
thoughts
> about this board - I would hate to see this group turn into anything
> more than an educational forum whereby many exchange ideas.  This is
not
> a place to lie in the weeds and pick off stock tips.  With that said,
we
> are currently looking at several different stocks.  We have let a
couple
> generic drug makers go by - leadership in this area - this is not a
> market for the weak at heart - one major set back in Iraq i.e. many
> casualties, the market will drop 5% in a blink of an eye.  The leaders
> get clipped for 10% or more.  Play small - be vigilant and let the
> market be your guide.
>
>
> Ed Gjertsen II
> ed@macktracks.com
>
>
> Confidentiality Notice: This e-mail message, including any
attachments,
> is for the sole use of the intended recipient(s) and may contain
> confidential and privileged information.  Any unauthorized review,
use,
> disclosure or distribution is prohibited.  If you are not the intended
> recipient, please contact the sender by reply e-mail and destroy all
> copies of the original message.
>
>
> -----Original Message-----
> From: owner-canslim@lists.xmission.com
> [mailto:owner-canslim@lists.xmission.com] On Behalf Of Tom Worley
> Sent: Thursday, March 27, 2003 4:22 PM
> To: CANSLIM
> Subject: [CANSLIM] EPIQ - c&h approaching pivot
>
> for the members with this group for some time, you know I like this
> stock,
> and currently own it for the 6th trip, plus have a large position in
my
> VR
> Fund.
>
> Traded up today 20 cents, on nearly 2X ADV, and has been building
volume
> in
> the handle for several days now despite the light volume in the
markets.
> Now
> only 26 cents off the high point in the handle.
>
> THIS IS NOT A RECOMMENDATION FOR ANYONE TO BUY, especially those that
do
> not
> like small and microcap stocks, or don't like fighting the trend. I am
> already up 30% on this trip alone, so I don't need any of you buying
it
> to
> move it up and make me profitable. The trend of "M" remains flat to
> negative, and many other c&h patterns have failed, or will failed, and
> there
> is no way to know if EPIQ will also fail. But it may prove to be worth
> watching, and learning from.
>
> Besides, it's been real quiet in the group, maybe this will give
someone
> something to talk about.
>
> Tom Worley
> stkguru@bellsouth.net
> AIM: TexWorley
>
>
>
> -
> -To subscribe/unsubscribe, email "majordomo@xmission.com"
> -In the email body, write "subscribe canslim" or
> -"unsubscribe canslim".  Do not use quotes in your email.
>
>
> -
> -To subscribe/unsubscribe, email "majordomo@xmission.com"
> -In the email body, write "subscribe canslim" or
> -"unsubscribe canslim".  Do not use quotes in your email.


- -
- -To subscribe/unsubscribe, email "majordomo@xmission.com"
- -In the email body, write "subscribe canslim" or
- -"unsubscribe canslim".  Do not use quotes in your email.


- ------=_NextPart_001_00AA_01C2F52C.B7146B10
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html>

<head>
<META HTTP-EQUIV=3D"Content-Type" CONTENT=3D"text/html; =
charset=3Dus-ascii">


<meta name=3DGenerator content=3D"Microsoft Word 10 (filtered)">

<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman";}
span.EmailStyle17
	{font-family:"Times New Roman";
	color:blue;
	font-weight:normal;
	font-style:normal;
	text-decoration:none none;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in .75in 1.0in .75in;}
div.Section1
	{page:Section1;}
- -->
</style>

</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple>

<div class=3DSection1>

<p class=3DMsoNormal><font size=3D2 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:10.0pt;color:blue'>Great comments </span></font><font =
size=3D2
  color=3Dblue><span =
style=3D'font-size:10.0pt;color:blue'>Nancy</span></font><font
size=3D2 color=3Dblue><span style=3D'font-size:10.0pt;color:blue'> =
&#8211; my
thoughts were not necessarily directed at Tom and definitely not a =
criticism of
this great board.&nbsp; There are members here who put a lot of time and =
effort
into guiding those looking to learn.&nbsp; My concern is that some here =
may only
want to take a fish out of the basket instead of learning to fish.&nbsp; =
This
is the most intelligent, well versed board that I have been involved =
with and hope
many here will make more than just a buck.&nbsp; </span></font></p>

<div>

<div>

<p class=3DMsoAutoSig><font size=3D3 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:12.0pt;color:blue'><img width=3D64 height=3D46
src=3D"cid:image001.gif@01C2F52C.B6C07EB0"></span></font></p>

<p class=3DMsoNormal><font size=3D3 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:12.0pt;color:blue'>&nbsp;</span></font></p>

<p class=3DMsoNormal><font size=3D2 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:10.0pt;color:blue'>Ed Gjertsen II</span></font></p>

<p class=3DMsoNormal><font size=3D2 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:10.0pt;color:blue'><a =
href=3D"mailto:ed@macktracks.com"><font
size=3D3><span =
style=3D'font-size:12.0pt'>ed@macktracks.com</span></font></a></span></fo=
nt></p>

<p class=3DMsoNormal><font size=3D3 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:12.0pt;color:blue'>&nbsp;</span></font></p>

<p class=3DMsoNormal><font size=3D3 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:12.0pt;color:blue'>&nbsp;</span></font></p>

<p class=3DMsoNormal><font size=3D2 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:10.0pt;color:blue'>Confidentiality Notice: This =
e-mail
message, including any attachments, is for the sole use of the intended
recipient(s) and may contain confidential and privileged =
information.&nbsp; Any
unauthorized review, use, disclosure or distribution is =
prohibited.&nbsp; If
you are not the intended recipient, please contact the sender by reply =
e-mail and
destroy all copies of the original message.</span></font></p>

</div>

</div>

<p class=3DMsoNormal><font size=3D2 color=3Dblue face=3D"Times New =
Roman"><span
style=3D'font-size:10.0pt;color:blue'>&nbsp;</span></font></p>

<p class=3DMsoNormal style=3D'margin-left:.5in'><font size=3D2 =
face=3DTahoma><span
style=3D'font-size:10.0pt;font-family:Tahoma'>-----Original =
Message-----<br>
<b><span style=3D'font-weight:bold'>From:</span></b>
owner-canslim@lists.xmission.com =
[mailto:owner-canslim@lists.xmission.com] <b><span
style=3D'font-weight:bold'>On Behalf Of </span></b>NANCY POLCARO<br>
<b><span style=3D'font-weight:bold'>Sent:</span></b> Monday, July 28, =
2003 12:45
PM<br>
<b><span style=3D'font-weight:bold'>To:</span></b> canslim<br>
<b><span style=3D'font-weight:bold'>Subject:</span></b> Re: [CANSLIM] =
EPIQ and
other thoughts</span></font></p>

<p class=3DMsoNormal style=3D'margin-left:.5in'><font size=3D3 =
face=3D"Times New Roman"><span
style=3D'font-size:12.0pt'>&nbsp;</span></font></p>

<div>

<p class=3DMsoNormal style=3D'margin-left:.5in'><font size=3D2 =
face=3DVerdana><span
style=3D'font-size:10.0pt;font-family:Verdana'>I have to say I disagree =
with your
thoughts on Toms message aabout EPIQ.. If he had said &quot;what do you =
think
about EPIQ&quot;.&nbsp; Instead of &quot;I like EPIQ&quot;. No would =
have
complained.&nbsp; I said that very thing about Yahoo a couple of weeks =
ago and
no one said anything to me for letting the cat out of the bag and =
drawing
attention to a stock that was doing well.&nbsp; I believe another one =
brought
up on the board was ONEV.&nbsp; Again asking for opinions.&nbsp; For the =
people
that are&nbsp; less experienced and learning in this terrible market, it =
may
actually help them make a buck.&nbsp; I think the board should set a =
rule for
the future where everyone who want to bring attention to a stock should =
say
&quot; What do you think about this stock&quot;&nbsp; Then it will bring =
it
to&nbsp;our attention, we can ask questions, we can get answers, and no =
one
will get upset for &quot; letting the cat out of the =
bag.&quot;nancy</span></font></p>

</div>

<div>

<p class=3DMsoNormal style=3D'margin-left:.5in'><font size=3D2 =
face=3DVerdana><span
style=3D'font-size:10.0pt;font-family:Verdana'>&nbsp;</span></font></p>

</div>

<blockquote style=3D'border:none;border-left:solid black =
1.5pt;padding:0in 0in 0in 4.0pt;
margin-left:3.75pt;margin-top:5.0pt;margin-right:0in;margin-bottom:5.0pt'=
>

<div>

<p class=3DMsoNormal style=3D'margin-left:.5in'><font size=3D2 =
face=3DArial><span
style=3D'font-size:10.0pt;font-family:Arial'>----- Original Message =
- -----</span></font></p>

</div>

<div>

<p class=3DMsoNormal =
style=3D'margin-left:.5in;background:#E4E4E4'><b><font size=3D2
color=3Dblack face=3DArial><span =
style=3D'font-size:10.0pt;font-family:Arial;
color:black;font-weight:bold'>From:</span></font></b><font size=3D2 =
color=3Dblack
face=3DArial><span =
style=3D'font-size:10.0pt;font-family:Arial;color:black'> =
Ian</span></font></p>

</div>

<div>

<p class=3DMsoNormal style=3D'margin-left:.5in'><b><font size=3D2 =
face=3DArial><span
style=3D'font-size:10.0pt;font-family:Arial;font-weight:bold'>Sent:</span=
></font></b><font
size=3D2 face=3DArial><span =
style=3D'font-size:10.0pt;font-family:Arial'> Monday,
July 28, 2003 9:24 AM</span></font></p>

</div>

<div>

<p class=3DMsoNormal style=3D'margin-left:.5in'><b><font size=3D2 =
face=3DArial><span
style=3D'font-size:10.0pt;font-family:Arial;font-weight:bold'>To:</span><=
/font></b><font
size=3D2 face=3DArial><span =
style=3D'font-size:10.0pt;font-family:Arial'>
canslim@lists.xmission.com</span></font></p>

</div>

<div>

<p class=3DMsoNormal style=3D'margin-left:.5in'><b><font size=3D2 =
face=3DArial><span
style=3D'font-size:10.0pt;font-family:Arial;font-weight:bold'>Subject:</s=
pan></font></b><font
size=3D2 face=3DArial><span =
style=3D'font-size:10.0pt;font-family:Arial'> Re:
[CANSLIM] EPIQ and other thoughts</span></font></p>

</div>

<div>

<p class=3DMsoNormal style=3D'margin-left:.5in'><font size=3D2 =
face=3DVerdana><span
style=3D'font-size:10.0pt;font-family:Verdana'>&nbsp;</span></font></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in'><font size=3D2 =
face=3DVerdana><span
style=3D'font-size:10.0pt;font-family:Verdana'>I would reiterate Ed's =
assertion
that generic pharma and a few other<br>
medicaldevice makers are leading this market. A couple of days ago, when =
the<br>
market was flat, I was watching about 15 pharma/medical stocks up 4% =
or<br>
more. It is the sector that I'd be most comfortable taking long =
positions in<br>
right now when the charts set up.<br>
<br>
<br>
<br>
Ian<br>
<br>
<br>
- ----- Original Message -----<br>
From: Edward W. Gjertsen II &lt;ed@macktracks.com&gt;<br>
To: &lt;canslim@lists.xmission.com&gt;<br>
Sent: Thursday, March 27, 2003 4:40 PM<br>
Subject: [CANSLIM] EPIQ and other thoughts<br>
<br>
<br>
&gt; Tom, Tom, Tom --- This is one we are watching as well - my own =
thoughts<br>
&gt; about this board - I would hate to see this group turn into =
anything<br>
&gt; more than an educational forum whereby many exchange ideas.&nbsp; =
This is
not<br>
&gt; a place to lie in the weeds and pick off stock tips.&nbsp; With =
that said,
we<br>
&gt; are currently looking at several different stocks.&nbsp; We have =
let a
couple<br>
&gt; generic drug makers go by - leadership in this area - this is not =
a<br>
&gt; market for the weak at heart - one major set back in Iraq i.e. =
many<br>
&gt; casualties, the market will drop 5% in a blink of an eye.&nbsp; The
leaders<br>
&gt; get clipped for 10% or more.&nbsp; Play small - be vigilant and let =
the<br>
&gt; market be your guide.<br>
&gt;<br>
&gt;<br>
&gt; Ed Gjertsen II<br>
&gt; ed@macktracks.com<br>
&gt;<br>
&gt;<br>
&gt; Confidentiality Notice: This e-mail message, including any =
attachments,<br>
&gt; is for the sole use of the intended recipient(s) and may =
contain<br>
&gt; confidential and privileged information.&nbsp; Any unauthorized =
review,
use,<br>
&gt; disclosure or distribution is prohibited.&nbsp; If you are not the
intended<br>
&gt; recipient, please contact the sender by reply e-mail and destroy =
all<br>
&gt; copies of the original message.<br>
&gt;<br>
&gt;<br>
&gt; -----Original Message-----<br>
&gt; From: owner-canslim@lists.xmission.com<br>
&gt; [mailto:owner-canslim@lists.xmission.com] On Behalf Of Tom =
Worley<br>
&gt; Sent: Thursday, March 27, 2003 4:22 PM<br>
&gt; To: CANSLIM<br>
&gt; Subject: [CANSLIM] EPIQ - c&amp;h approaching pivot<br>
&gt;<br>
&gt; for the members with this group for some time, you know I like =
this<br>
&gt; stock,<br>
&gt; and currently own it for the 6th trip, plus have a large position =
in my<br>
&gt; VR<br>
&gt; Fund.<br>
&gt;<br>
&gt; Traded up today 20 cents, on nearly 2X ADV, and has been building =
volume<br>
&gt; in<br>
&gt; the handle for several days now despite the light volume in the =
markets.<br>
&gt; Now<br>
&gt; only 26 cents off the high point in the handle.<br>
&gt;<br>
&gt; THIS IS NOT A RECOMMENDATION FOR ANYONE TO BUY, especially those =
that do<br>
&gt; not<br>
&gt; like small and microcap stocks, or don't like fighting the trend. I =
am<br>
&gt; already up 30% on this trip alone, so I don't need any of you =
buying it<br>
&gt; to<br>
&gt; move it up and make me profitable. The trend of &quot;M&quot; =
remains flat
to<br>
&gt; negative, and many other c&amp;h patterns have failed, or will =
failed, and<br>
&gt; there<br>
&gt; is no way to know if EPIQ will also fail. But it may prove to be =
worth<br>
&gt; watching, and learning from.<br>
&gt;<br>
&gt; Besides, it's been real quiet in the group, maybe this will give =
someone<br>
&gt; something to talk about.<br>
&gt;<br>
&gt; Tom Worley<br>
&gt; stkguru@bellsouth.net<br>
&gt; AIM: TexWorley<br>
&gt;<br>
&gt;<br>
&gt;<br>
&gt; -<br>
&gt; -To subscribe/unsubscribe, email =
&quot;majordomo@xmission.com&quot;<br>
&gt; -In the email body, write &quot;subscribe canslim&quot; or<br>
&gt; -&quot;unsubscribe canslim&quot;.&nbsp; Do not use quotes in your =
email.<br>
&gt;<br>
&gt;<br>
&gt; -<br>
&gt; -To subscribe/unsubscribe, email =
&quot;majordomo@xmission.com&quot;<br>
&gt; -In the email body, write &quot;subscribe canslim&quot; or<br>
&gt; -&quot;unsubscribe canslim&quot;.&nbsp; Do not use quotes in your =
email.<br>
<br>
<br>
- -<br>
- -To subscribe/unsubscribe, email &quot;majordomo@xmission.com&quot;<br>
- -In the email body, write &quot;subscribe canslim&quot; or<br>
- -&quot;unsubscribe canslim&quot;.&nbsp; Do not use quotes in your =
email.</span></font></p>

</blockquote>

</div>

</body>

</html>

- ------=_NextPart_001_00AA_01C2F52C.B7146B10--

- ------=_NextPart_000_00A9_01C2F52C.B7146B10
Content-Type: application/octet-stream;
	name="image001.gif"
Content-Transfer-Encoding: base64
Content-ID: <image001.gif@01C2F52B.4869D750>
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- ------=_NextPart_000_00A9_01C2F52C.B7146B10
Content-Type: application/octet-stream;
	name="image001.gif"
Content-Transfer-Encoding: base64
Content-ID: <image001.gif@01C2F52B.BC5E4A10>
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- ------=_NextPart_000_00A9_01C2F52C.B7146B10
Content-Type: application/octet-stream;
	name="image001.gif"
Content-Transfer-Encoding: base64
Content-ID: <image001.gif@01C2F52C.3636EA90>
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- ------=_NextPart_000_00A9_01C2F52C.B7146B10
Content-Type: application/octet-stream;
	name="image001.gif"
Content-Transfer-Encoding: base64
Content-ID: <image001.gif@01C2F52C.A2F9EF10>
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- ------=_NextPart_000_00A9_01C2F52C.B7146B10
Content-Type: application/octet-stream;
	name="image001.gif"
Content-Transfer-Encoding: base64
Content-ID: <image001.gif@01C2F52C.B6C07EB0>
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- ------=_NextPart_000_00A9_01C2F52C.B7146B10--


- -
- -To subscribe/unsubscribe, email "majordomo@xmission.com"
- -In the email body, write "subscribe canslim" or
- -"unsubscribe canslim".  Do not use quotes in your email.

Previous Article (by Date): Re: [CANSLIM] EPIQ and other thoughts "NANCY POLCARO"
Top of Thread: Re: [CANSLIM] EPIQ and other thoughts Ian
Articles sorted by: [Date] [Author] [Subject]


Go to Jeff Salisbury LWGate Home Page.